NanoString Technologies appoints Kirk Malloy to board
Dr. Malloy is a senior healthcare executive with more than 20 years of leadership in life science tools, applied markets and molecular diagnostics.
He is currently founder and principal at BioAdvisors, where he provides strategic consulting services to life science, genomic and diagnostic companies.
Dr. Malloy's previous experience includes a 13-year career at Illumina, Inc., where he was most recently Senior Vice President and General Manager of Life Sciences & Applied Markets.
He served as Director of Technical Support at Biosite where he helped build their point-of-care cardiovascular diagnostics test business.
Dr. Malloy also held various management roles at Qiagen N.V., where he helped build the North American commercial organization.
He currently serves as lead director for Organovo Holdings as well as a director for three privately held companies - Edico Genome, iGenomx and Agilome.
Dr. Malloy received his B.S. in Biology and Marine Science from the University of Miami, and his M.S. and Ph.D. in Marine Biology and Biochemistry from the University of Delaware. ■
LATEST MOVES FROM Washington
- Expedia appoints Mark Okerstrom as CEO
- Kelley Hall joins Nordstrom as senior vice president
- Apptio appoints Kathleen Philips to board
- Timberland Bancorp appoints Kathy D. Leodler to board
- HaloSource appoints Craig Crowell to board as CFO
More inside POST
DP World EBITDA margin was 53.4 Earnings